Genital Herpes Simplex Virus Type 2 Infection in Humanized HIV-Transgenic Mice Triggers HIV Shedding and Is Associated With Greater Neurological Disease
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genital Herpes Simplex Virus Type 2 Infection in Humanized HIV-Transgenic Mice Triggers HIV Shedding and Is Associated With Greater Neurological Disease
Authors
Keywords
-
Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 209, Issue 4, Pages 510-522
Publisher
Oxford University Press (OUP)
Online
2013-08-30
DOI
10.1093/infdis/jit472
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Secretory Leukocyte Protease Inhibitor Reverses Inhibition by CNS Myelin, Promotes Regeneration in the Optic Nerve, and Suppresses Expression of the Transforming Growth Factor- Signaling Protein Smad2
- (2013) S. S. Hannila et al. JOURNAL OF NEUROSCIENCE
- Regulation of Progranulin Expression in Human Microglia and Proteolysis of Progranulin by Matrix Metalloproteinase-12 (MMP-12)
- (2012) Hyeon-Sook Suh et al. PLoS One
- Imbalanced Production of Cytokines by T Cells Associates with the Activation/Exhaustion Status of Memory T Cells in Chronic HIV Type 1 Infection
- (2011) Kaori Nakayama et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Characterization of a Human Cervical CD4+ T Cell Subset Coexpressing Multiple Markers of HIV Susceptibility
- (2011) L. R. McKinnon et al. JOURNAL OF IMMUNOLOGY
- Role of IL-17 and Th17 Cells in Herpes Simplex Virus-Induced Corneal Immunopathology
- (2011) A. Suryawanshi et al. JOURNAL OF IMMUNOLOGY
- Bridging the Gap between Preclinical and Clinical Microbicide Trials: Blind Evaluation of Candidate Gels in Murine Models of Efficacy and Safety
- (2011) Theodore J. Segarra et al. PLoS One
- Prevalence of Herpes Simplex Virus Type 2 Infection, Human Immunodeficiency Virus/Herpes Simplex Virus Type 2 Coinfection, and Associated Risk Factors in a National, Population-Based Survey in Kenya
- (2011) Nelly Mugo et al. SEXUALLY TRANSMITTED DISEASES
- Recurrent vaginal shedding of herpes simplex type 2 virus in the mouse and effects of antiviral therapy
- (2010) Nicholas Farley et al. ANTIVIRAL RESEARCH
- HSV Type 2 Infection Increases HIV DNA Detection in Vaginal Tissue of Mice Expressing Human CD4 and CCR5
- (2009) M. Reza Zariffard et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Susceptibility to genital herpes as a biomarker predictive of increased HIV risk: expansion of a murine model of microbicide safety
- (2009) Sarah S Wilson et al. ANTIVIRAL THERAPY
- A Macaque Model to Study Vaginal HSV-2/Immunodeficiency Virus Co-Infection and the Impact of HSV-2 on Microbicide Efficacy
- (2009) Federica Crostarosa et al. PLoS One
- Neurological Complications of Herpes Simplex Virus Type 2 Infection
- (2008) Joseph R. Berger et al. ARCHIVES OF NEUROLOGY
- Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections
- (2008) J. M. Brenchley et al. BLOOD
- Effect of mifepristone on the expression of endometrial secretory leukocyte protease inhibitor in new medroxyprogesterone acetate users
- (2008) A LI et al. FERTILITY AND STERILITY
- Herpes Simplex Virus Downregulates Secretory Leukocyte Protease Inhibitor: a Novel Immune Evasion Mechanism
- (2008) E. Fakioglu et al. JOURNAL OF VIROLOGY
- Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial
- (2008) Connie Celum et al. LANCET
- Effect of Herpes Simplex Suppression on Incidence of HIV among Women in Tanzania
- (2008) Deborah Watson-Jones et al. NEW ENGLAND JOURNAL OF MEDICINE
- Relief of Preintegration Inhibition and Characterization of Additional Blocks for HIV Replication in Primary Mouse T Cells
- (2008) Jing-xin Zhang et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started